Genßler, S., Burger, M. C., Zhang, C., Oelsner, S., Mildenberger, I., Wagner, M., . . . Wels, W. S. (2016). Dual targeting of glioblastoma with chimeric antigen receptor-engineered natural killer cells overcomes heterogeneity of target antigen expression and enhances antitumor activity and survival. OncoImmunology, 5(4), N.PAG. https://doi.org/10.1080/2162402X.2015.1119354
Chicago Style (17th ed.) CitationGenßler, Sabrina, Michael C. Burger, Congcong Zhang, Sarah Oelsner, Iris Mildenberger, Marlies Wagner, Joachim P. Steinbach, and Winfried S. Wels. "Dual Targeting of Glioblastoma with Chimeric Antigen Receptor-engineered Natural Killer Cells Overcomes Heterogeneity of Target Antigen Expression and Enhances Antitumor Activity and Survival." OncoImmunology 5, no. 4 (2016): N.PAG. https://doi.org/10.1080/2162402X.2015.1119354.
MLA (9th ed.) CitationGenßler, Sabrina, et al. "Dual Targeting of Glioblastoma with Chimeric Antigen Receptor-engineered Natural Killer Cells Overcomes Heterogeneity of Target Antigen Expression and Enhances Antitumor Activity and Survival." OncoImmunology, vol. 5, no. 4, 2016, p. N.PAG, https://doi.org/10.1080/2162402X.2015.1119354.
